MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KALV made $13,692K in revenue. -$49,155K in net income. Net profit margin of -359.01%.

Income Overview

Revenue
$13,692K
Net Income
-$49,155K
Net Profit Margin
-359.01%
EPS
-$0.92
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-07-31
2024-10-31
Product revenue, net
13,692 1,426 -
General and administrative expense, total
--29,201
Cost of revenue
1,232 590 -
Research and development
11,993 15,162 16,610
Selling, general and administrative
46,517 44,683 -
Total operating expenses
59,742 60,435 45,811
Operating loss
-46,050 -59,009 -45,811
Interest income
1,875 1,849 1,357
Interest expense
4,757 3,522 -
Foreign currency exchange (loss) gain
-884 1,925 67
Other income, net
2,491 818 2,119
Total other (expense) income
-1,275 1,070 3,543
Loss before income tax expense
-47,325 -57,939 -
Income tax expense
2,157 2,157 -
Net loss
-49,482 -60,096 -42,268
Foreign currency translation gain (loss)
911 -604 166
Unrealized holding gain on marketable securities
187 18 651
Reclassification adjustment for realized holding gain on marketable securities included in net loss
771 587 649
Total other comprehensive (loss) income
327 -1,173 168
Comprehensive loss
-49,155 -61,269 -42,100
Earnings per share, basic
-0.92 -1.12 -0.91
Earnings per share, diluted
-0.92 -1.12 -0.91
Weighted average number of shares outstanding, basic
53,883,681 53,497,128 46,695,220
Weighted average number of shares outstanding, diluted
53,883,681 53,497,128 46,695,220
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized holding gain onmarketable securities$187K Foreign currencytranslation gain (loss)$911K Comprehensive loss-$49,155K Total othercomprehensive (loss) income$327K Reclassification adjustment forrealized holding gain on...$771K Net loss-$49,482K Income tax expense$2,157K Loss before incometax expense-$47,325K Total other (expense)income-$1,275K Operating loss-$46,050K Other income, net$2,491K Interest income$1,875K Product revenue, net$13,692K Foreign currencyexchange (loss) gain-$884K Interest expense$4,757K Total operatingexpenses$59,742K Selling, general andadministrative$46,517K Research and development$11,993K Cost of revenue$1,232K

KalVista Pharmaceuticals, Inc. (KALV)

KalVista Pharmaceuticals, Inc. (KALV)